$9.38
0.16% today
Nasdaq, Apr 02, 09:33 pm CET
ISIN
US0453961080
Symbol
ASMB
Sector
Industry

Assembly Biosciences, Inc. Stock News

Neutral
GlobeNewsWire
13 days ago
– Four development candidates in clinical studies with data anticipated this year, continuing rapid progress of antiviral pipeline –
Neutral
GlobeNewsWire
about one month ago
– Phase 1a study will evaluate single and multiple ascending doses of ABI-6250 in healthy participants with data expected in Q3 2025 – – Biomarker of ABI-6250 target engagement, serum bile acids, will be assessed in addition to safety and pharmacokinetic measures – SOUTH SAN FRANCISCO, Calif., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company d...
Neutral
GlobeNewsWire
about one month ago
– ABI-1179 was well-tolerated, with a half-life of approximately four days and high exposure across the dose range evaluated supporting the potential for once-weekly oral administration at a low dose –
Neutral
GlobeNewsWire
3 months ago
– ABI-4334 was well-tolerated with a favorable safety profile and half-life supporting once-daily oral dosing observed –

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today